Skip to main content

Current Status of Convalescent Plasma to Treat COVID-19

From the 2020 Joint Annual Meeting (June 29, 2020)
Presented by Michael Joyner, MD
This presentation will outline what convalescent plasma is and how it can be used to treat COVID-19, including what is currently known about its’ safety and efficacy.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

  1. Define Convalescent plasma
  2. Describe the use of convalescent plasma to treat COVID-19
  3. Discuss the lessons learned from this use

CE ACCREDITATION
This recorded presentation is P.A.C.E. ® accredited. The instruction level for this activity is Intermediate. One-half (.5) P.A.C.E. ® contact hour in the area of Immunology/Immunohematology will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.